331 related articles for article (PubMed ID: 29395676)
21. Super-Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer.
Hoyt K
J Ultrasound Med; 2024 Jun; 43(6):1099-1107. PubMed ID: 38411352
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic efficiency of the perfusion-related parameters in assessing the vascular disrupting agent (CA4P) response in a rabbit VX2 liver tumor model.
Meng F; Zou B; Yang R; Duan Q; Qian T
Acta Radiol; 2022 Sep; 63(9):1147-1156. PubMed ID: 34279135
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
Amadori M; Barone D; Scarpi E; Oboldi D; Amadori E; Bandi G; Rossi A; Ferroni F; Ragazzini A; Casadei Gardini A; Frassineti GL; Gavelli G; Passardi A
Eur Radiol; 2018 Jul; 28(7):2969-2978. PubMed ID: 29417252
[TBL] [Abstract][Full Text] [Related]
24. Combretastatin A4 phosphate: a novel vascular disrupting agent.
Nagaiah G; Remick SC
Future Oncol; 2010 Aug; 6(8):1219-28. PubMed ID: 20799867
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model.
Zhou JH; Cao LH; Zheng W; Liu M; Han F; Li AH
AJR Am J Roentgenol; 2011 Jan; 196(1):W13-7. PubMed ID: 21178025
[TBL] [Abstract][Full Text] [Related]
27. Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer.
Ng QS; Goh V; Carnell D; Meer K; Padhani AR; Saunders MI; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1375-80. PubMed ID: 17275203
[TBL] [Abstract][Full Text] [Related]
28. The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats.
Liu Y; De Keyzer F; Wang Y; Wang F; Feng Y; Chen F; Yu J; Liu J; Song S; Swinnen J; Bormans G; Oyen R; Huang G; Ni Y
Int J Cancer; 2018 Oct; 143(7):1817-1828. PubMed ID: 29707770
[TBL] [Abstract][Full Text] [Related]
29. Characterizing the tumor response to treatment with combretastatin A4 phosphate.
Salmon BA; Siemann DW
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):211-7. PubMed ID: 17448875
[TBL] [Abstract][Full Text] [Related]
30. Contrast-Enhanced Ultrasonography versus Contrast-Enhanced Magnetic Resonance Imaging in the Diagnosis of Mediastinal Tumors.
Pan J; Chen W; Zhang H; Huang X; Huang X
Ultrasound Med Biol; 2021 Feb; 47(2):261-271. PubMed ID: 33153806
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of bone microvascularization after osteocutaneous flap transplantation using contrast-enhanced ultrasound (CEUS).
Geis S; Prantl L; Mueller S; Gosau M; Lamby P; Jung EM
Ultraschall Med; 2013 Jun; 34(3):272-9. PubMed ID: 23709242
[TBL] [Abstract][Full Text] [Related]
32. Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study.
Qiu T; Wang H; Song J; Ling W; Shi Y; Guo G; Luo Y
Exp Anim; 2018 May; 67(2):117-126. PubMed ID: 29081454
[TBL] [Abstract][Full Text] [Related]
33. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
Zhuo J; Fu W; Liu S
Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
[TBL] [Abstract][Full Text] [Related]
34. Cerebral perfusion in perinatal hypoxia and resuscitation assessed by transcranial contrast-enhanced ultrasound and 3 T MRI in newborn pigs.
de Lange C; Brabrand K; Emblem KE; Bjornerud A; Løberg EM; Saugstad OD; Munkeby BH
Invest Radiol; 2011 Nov; 46(11):686-96. PubMed ID: 21730873
[TBL] [Abstract][Full Text] [Related]
35. Gray-scale contrast-enhanced ultrasonography for quantitative evaluation of the blood perfusion of the sciatic nerves with crush injury.
Wang Y; Tang P; Zhang L; Wan W; He C; Tang J
Acad Radiol; 2011 Oct; 18(10):1285-91. PubMed ID: 21784669
[TBL] [Abstract][Full Text] [Related]
36. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma.
Wang Z; Tang J; An L; Wang W; Luo Y; Li J; Xu J
J Ultrasound Med; 2007 Jun; 26(6):757-62. PubMed ID: 17526607
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.
Shin HJ; Chang EY; Lee HS; Hong JH; Park G; Kim HG; Kim MJ; Lee MJ
World J Gastroenterol; 2015 Mar; 21(9):2614-21. PubMed ID: 25759528
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced ultrasound and transient arterial occlusion for quantification of arterial perfusion reserve in peripheral arterial disease.
Amarteifio E; Wormsbecher S; Krix M; Demirel S; Braun S; Delorme S; Böckler D; Kauczor HU; Weber MA
Eur J Radiol; 2012 Nov; 81(11):3332-8. PubMed ID: 22285606
[TBL] [Abstract][Full Text] [Related]
40. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.
Stevenson JP; Rosen M; Sun W; Gallagher M; Haller DG; Vaughn D; Giantonio B; Zimmer R; Petros WP; Stratford M; Chaplin D; Young SL; Schnall M; O'Dwyer PJ
J Clin Oncol; 2003 Dec; 21(23):4428-38. PubMed ID: 14645433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
